FDA
approval
· 2018-03-07
FDA Approved: ONDANSETRON — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
Summary
The FDA approved a supplemental application for ondansetron under an ANDA held by PAI Holdings dba PAI Pharma, indicating a supplemental regulatory action for t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ONDANSETRON (ONDANSETRON)